Meningioma in vivo research is hampered by the difficulty of establishing an easy and reproducible orthotopic model able to mimic the characteristics of a human meningioma. Moreover, leptomeningeal dissemination and high mortality are often associated with such orthotopical models, making them useless for clinical translation studies. An optimized method for inducing meningiomas in nude mice at two different sites is described in this paper and the high reproducibility and low mortality of the models are demonstrated. Skull base meningiomas were induced in the auditory meatus and convexity meningiomas were induced on the brain surface of 23 and 24 nude mice, respectively. Both models led to the development of a mass easily observable by imaging methods. Dynamic contrast enhanced MRI was used as a tool to monitor and characterize the pathology onset and progression. At the end of the study, histology was performed to confirm the neoplastic origin of the diseased mass.
| INTRODUCTION
This study focuses on the induction of two orthotopic meningioma models: a skull base meningioma of the auditory meatus, and a convexity meningioma. The models were selected as examples of meningioma tumors in mice, to be used in preclinical studies for translational research, being examples of brain tumors with the highest incidence. Despite the relatively low mortality characterizing these human meningiomas, the development of early diagnostic tools and/or effective therapies is extremely important to improve the outcome of the medical treatment of this pathology. 1, 2 Both models were induced using the CH157MN cell line, isolated in 1977 from a 41-year-old woman. 3 This line was selected because of its ability to reproduce histological, immunohistochemical and structural features of human meningioma. A CH157MN model has been described by Ragel et al 4, 5 in 2007 and 2008, but these papers focused on characterization of the model via luciferase rather than on a description of the induction or characterization by MRI (tumors
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| PROTOCOL
All the procedures involving animals were conducted according to 
| Tumor induction
Mice were subcutaneously injected with carprofen (5 mg/kg) 1 hour before the surgery. Anesthesia was induced with sevoflurane gas and then maintained systemically with Rompun ® (5 mg/kg) and Zoletil ® (40 mg/kg). Each mouse was then mounted on the stereotaxic apparatus and its temperature was continuously monitored and maintained in the range 36.5-38.5°C. After cleaning the skin with a disinfectant (iodopovidone), a local anesthesia was administered (lidocaine) at a dose of 3 mg/kg. Bregma was then exposed and the induction sites identified using the following coordinates: for the convexity site, was injected manually at a rate of approximately 1 μL/3 min using a Hamilton syringe with 25G needle. The hole was closed using either bone wax or surgical glue after removing the needle, and the mouse was removed from the stereotaxic apparatus. The wound was sutured with surgical glue or silk thread. Carprofen (5 mg/kg) was subcutaneously administered for 3 days after surgery. For more information, see Supporting Information.
| Imaging protocol
Mice were imaged once or twice a week using a 1 T Icon (Bruker Biospin, Ettlingen, Germany) scanner. After preliminary anatomical scans, MSME sequences were acquired before and after the intravenous administration of the GBCA. The following parameters were set: matrix size = 128 × 128, field of view = 1.6 × 1.6 cm, slice thickness 1.2 mm, TE (echo time) = 9.2 milliseconds, TR (repetition time) = 350 milliseconds, acquisition time = 90 seconds, NA = 2.
| RESULTS
CH157MN meningiomas were induced in 47 nude mice, according to the experimental protocols summarized in Table 1 . The induction was successful in 35/47 animals. Specifically:
• 15/24 mice developed skull base meningiomas (four mice did not survive the systemic anesthesia and one showed clinical signs immediately after the surgery; four mice did not develop any tumors).
• 20/23 mice developed convexity meningiomas (one mouse did not survive the systemic anesthesia; two mice did not develop any tumors).
As detailed in Table 1 , once the inoculation site had been set, different experimental conditions were tested (ie the cell number and the method adopted to suture the surgical wound) to optimize the protocol.
The convexity meningioma model was generally more successful than the skull base model, in terms of both surgical procedure and animal welfare. Specifically, the intra-operative mortality was lower for three out of four groups inoculated superficially, indicating, as expected, a minor surgery risk, since the needle stops at the surface rather than passing through the brain to reach the auditory meatus. Even after surgery, the occurrence of clinical signs was more severe in the skull base model, with the appearance of unsteady gait, domed head and loss of equilibrium. Loss of equilibrium was probably due to the specific location of the tumor in the auditory meatus. A further advantage of the convexity model was that the tumor take rate was superior. Tumor volume, growth rate and maximum enhancement after GBCA administration were comparable between the two sites. All the different procedures to close the skull hole adopted for both the skull base and convexity meningioma models were effective at avoiding the appearance of any extra-cranial mass. Surgical glue is preferred to silk thread for suturing the wound, to prevent the animal from opening the wound by over-grooming.
A standard needle was used during cell inoculation in only three animals. For all the other experimental groups the tip of the needle was cut, since only one animal out of the three inoculated using a standard needle developed an observable tumor mass; most likely the standard tip prevented release of tumor cells. The feasibility and high reproducibility of these pathological models indicates their suitability for GBCA validation MRI studies.
The precise location of the meningioma tumors, as seen with MRI, has been shown to mimic the complex situations in human patients. 8 The enhanced signals for tumor masses obtained after GBCA administration in the investigated orthotopic meningiomas shows that these models could be used to "bridge" the gap between clinical and preclinical efficacy studies.
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